Bancroft Charles A 4

What Happened

• Charles A. Bancroft, a director of Kodiak Sciences, was granted a derivative award covering 17,731 shares on June 30, 2026. The Form 4 reports the grant as a derivative security with a reported price of $0 (transaction code A — award/grant).

Key Details

• Transaction date: 2026-06-30 (reported on Form 4 filed 2026-07-02).
• Transaction type/code: A (award/grant) of a derivative security; reported price $0.00 for 17,731 shares.
• Shares owned after transaction: Not specified in the provided excerpt of the filing (see the full Form 4 for total holdings).
• Vesting: Footnote states 100% of the shares subject to the option vest upon the earlier of June 30, 2027 or one day prior to the issuer’s next annual meeting after the grant date, provided Bancroft remains a board member through the vesting date.
• Filing timeliness: Form 4 was filed July 2, 2026 for a June 30, 2026 grant — appears to be timely (within the standard two-business-day window).

Context

• This is a director compensation award (derivative/option grant), which is common for board service and does not reflect an open-market purchase or sale by the insider. The award will vest according to the specified schedule if the director remains on the board; it does not indicate an immediate sale or cash transaction. For exact holdings, exercise price (if any), and other details, consult the full Form 4 filing.